Lundbeck’s sales increased by 11% (+6% in local currencies) to DKK 13.6 billion in the first nine months of 2022
HIGHLIGHTS Growth of Lundbeck’s strategic brands accelerates further growing 30% (+19% in local currencies) in the first nine months of 2022 thereby reaching DKK 8.8 billion, representing 65% of overall revenue. · Brintellix[®]/Trintellix[®]: +24% reported to DKK 3,177 million (+15% in local currencies) · Rexulti[®]/Rxulti[®]: +33% reported to DKK 2,817 million (+19% in local currencies) · Abilify Maintena[®]: +20% reported to DKK 2,164 million (+13% in local currencies) · Vyepti[®]: +105% reported to DKK 672 million (+82% in local currencies) All markets contribute to